Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Glutazest
- Development stage
- Unknown
- Lead developer
- IGP Mediventures
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Glutazest is an oral nutraceutical supplement developed by IGP Mediventures, specifically formulated for cosmetic skin support and overall skin health. It contains a combination of antioxidant ingredients, including L-glutathione, vitamin C, vitamin E, alpha-lipoic acid, grape seed extract, and green tea extract. The product is marketed to promote radiant skin and reduce the appearance of dark spots and wrinkles by leveraging the synergistic antioxidant properties of its components to combat oxidative stress and potentially inhibit melanin production through tyrosinase inhibition.
- Brand names
- Glutazest
- Other names
- Glutazest Capsules for Skin
02
Targets
TYR (Tyrosinase)
Beyond the preview
Go deeper on Glutazest.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Glutazest.